arrow_left You’re on the news side, go back to data on ImmunoGen

Latest news about ImmunoGen

349 days ago

There has been 2 news about ImmunoGen in the past from 2 different sources and amongst 2 sections

Evolution

Here is the latest:

CNBC News
Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen for $10 billion
Read link
Nov 30, 2023
The Wall Street Journal
AbbVie to Buy ImmunoGen for More Than $10 Billion
Read link
Nov 30, 2023

Distribution by section

The coverage span across 2 distinct sections:

Distribution by publisher

There has been 2 publishers reporting on this, here are the top ones:

  • CNBC News (50%)
  • The Wall Street Journal (50%)

Details

This content can be used under the CC BY 4.0 license